Key result
Anakinra suppressed ventricular arrhythmias refractory to conventional therapies in a young patient with severe autoimmune lymphocytic myocarditis.
Why the study?
Does anakinra suppress refractory ventricular arrhythmias in a patient with severe autoimmune lymphocytic myocarditis?
Does anakinra suppress refractory ventricular arrhythmias in a patient with severe autoimmune lymphocytic myocarditis?
Anakinra may be an effective targeted therapy for suppressing refractory ventricular arrhythmias in patients with severe autoimmune lymphocytic myocarditis.
Answers are grounded in this paper and cite their sources.
May support anakinra in refractory VA from autoimmune myocarditis; hypothesis-generating, needs prospective validation.
IL-1 inhibition with anakinra suppressed ventricular arrhythmias refractory to conventional therapies in severe myocarditis.
No takes yet. Share an insight, caveat, or question.
Bello et al. (2020) studied this question. Anakinra suppressed ventricular arrhythmias refractory to conventional therapies in a young patient with severe autoimmune lymphocytic myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: